Sharon X. Wen

Array ( [id] => 10076309 [patent_doc_number] => 09114144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Kallikrein-inhibitor therapies' [patent_app_type] => utility [patent_app_number] => 13/228300 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20212 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742259 [patent_doc_number] => 20120020962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHOD OF DEPLETING REGULATORY T CELL' [patent_app_type] => utility [patent_app_number] => 13/225811 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17897 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020962.pdf [firstpage_image] =>[orig_patent_app_number] => 13225811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895088 [patent_doc_number] => 20150050287 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-02-19 [patent_title] => 'ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/820278 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39852 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895088 [patent_doc_number] => 20150050287 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-02-19 [patent_title] => 'ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/820278 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39852 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650800 [patent_doc_number] => 20110300069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => ' Methods of Using Labeled Ligands Having Human CD4 Specificity' [patent_app_type] => utility [patent_app_number] => 13/211414 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8565 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300069.pdf [firstpage_image] =>[orig_patent_app_number] => 13211414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650876 [patent_doc_number] => 20110300145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Interferon Alpha Antibodies And Their Uses' [patent_app_type] => utility [patent_app_number] => 13/211092 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30425 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300145.pdf [firstpage_image] =>[orig_patent_app_number] => 13211092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650884 [patent_doc_number] => 20110300153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTIBODY PRODUCED USING OSTRICH AND METHOD FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/210516 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6599 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300153.pdf [firstpage_image] =>[orig_patent_app_number] => 13210516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652067 [patent_doc_number] => 20110301336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTIBODY PRODUCED USING OSTRICH AND METHOD FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/210512 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6603 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301336.pdf [firstpage_image] =>[orig_patent_app_number] => 13210512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776317 [patent_doc_number] => 20120039895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PHOSPHORYCHOLINE CONJUGATES AND CORRESPONDING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/208138 [patent_app_country] => US [patent_app_date] => 2011-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8755 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039895.pdf [firstpage_image] =>[orig_patent_app_number] => 13208138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903660 [patent_doc_number] => 20130171163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Inhibition of LAR Phosphatase to Enhance Therapeutic Angiogenesis' [patent_app_type] => utility [patent_app_number] => 13/813964 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30406 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754469 [patent_doc_number] => 20120027686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'HK1-BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/192786 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 54297 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027686.pdf [firstpage_image] =>[orig_patent_app_number] => 13192786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8174222 [patent_doc_number] => 20120108797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/193167 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47416 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108797.pdf [firstpage_image] =>[orig_patent_app_number] => 13193167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977039 [patent_doc_number] => 09023346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Method of treating stroke with tenecteplase' [patent_app_type] => utility [patent_app_number] => 13/189413 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10567 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13189413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662736 [patent_doc_number] => 20110312005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Enzymatic modification of cell-surface H antigen by glycosyltransferases' [patent_app_type] => utility [patent_app_number] => 13/137096 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7263 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312005.pdf [firstpage_image] =>[orig_patent_app_number] => 13137096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733275 [patent_doc_number] => 20120015867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'THERAPEUTIC PEPTIDES AND METHOD' [patent_app_type] => utility [patent_app_number] => 13/181323 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22575 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015867.pdf [firstpage_image] =>[orig_patent_app_number] => 13181323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138559 [patent_doc_number] => 20120093818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/174423 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 153 [patent_figures_cnt] => 153 [patent_no_of_words] => 78137 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794132 [patent_doc_number] => 09403882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Sulfation of Wnt pathway proteins' [patent_app_type] => utility [patent_app_number] => 13/170634 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13170634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335129 [patent_doc_number] => 20120201835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'ANTIBODIES SPECIFIC FOR DKK-1' [patent_app_type] => utility [patent_app_number] => 13/169523 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20513 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731537 [patent_doc_number] => 20120014952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/162479 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37131 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014952.pdf [firstpage_image] =>[orig_patent_app_number] => 13162479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733288 [patent_doc_number] => 20120015872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/162434 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37438 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015872.pdf [firstpage_image] =>[orig_patent_app_number] => 13162434 [rel_patent_id] =>[rel_patent_doc_number] =>)